These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26246321)

  • 1. Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.
    Sathananthan M; Shah M; Edens KL; Grothe KB; Piccinini F; Farrugia LP; Micheletto F; Man CD; Cobelli C; Rizza RA; Camilleri M; Vella A
    J Nutr; 2015 Sep; 145(9):2046-51. PubMed ID: 26246321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.
    Malandrucco I; Pasqualetti P; Giordani I; Manfellotto D; De Marco F; Alegiani F; Sidoti AM; Picconi F; Di Flaviani A; Frajese G; Bonadonna RC; Frontoni S
    Am J Clin Nutr; 2012 Mar; 95(3):609-13. PubMed ID: 22318758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
    Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
    Am J Clin Nutr; 2016 Jan; 103(1):66-70. PubMed ID: 26607942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects.
    Cersosimo E; Gastaldelli A; Cervera A; Wajcberg E; Sriwijilkamol A; Fernandez M; Zuo P; Petz R; Triplitt C; Musi N; DeFronzo RA
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1763-70. PubMed ID: 21411546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carbohydrate restriction on postprandial glucose metabolism,
    Skytte MJ; Samkani A; Astrup A; Frystyk J; Rehfeld JF; Holst JJ; Madsbad S; Burling K; Fenger M; Thomsen MN; Larsen TM; Krarup T; Haugaard SB
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E7-E18. PubMed ID: 33103448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
    Ravikumar B; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
    Diabetes; 2008 Sep; 57(9):2288-95. PubMed ID: 18535187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
    Ferrannini E; Muscelli E; Frascerra S; Baldi S; Mari A; Heise T; Broedl UC; Woerle HJ
    J Clin Invest; 2014 Feb; 124(2):499-508. PubMed ID: 24463454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].
    Tang W; Chen Y; Pan M; Chen L; Zhang L; Wang T; Zhang X; Zhang P; Zheng C; Yu B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):411-416. PubMed ID: 28440522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
    DeFronzo RA; Okerson T; Viswanathan P; Guan X; Holcombe JH; MacConell L
    Curr Med Res Opin; 2008 Oct; 24(10):2943-52. PubMed ID: 18786299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
    Sjöstrand M; Iqbal N; Lu J; Hirshberg B
    Diabetes Res Clin Pract; 2014 Aug; 105(2):185-91. PubMed ID: 24947443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-protein breakfast induces greater insulin and glucose-dependent insulinotropic peptide responses to a subsequent lunch meal in individuals with type 2 diabetes.
    Park YM; Heden TD; Liu Y; Nyhoff LM; Thyfault JP; Leidy HJ; Kanaley JA
    J Nutr; 2015 Mar; 145(3):452-8. PubMed ID: 25733459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
    Heise T; Mari A; DeVries JH; Urva S; Li J; Pratt EJ; Coskun T; Thomas MK; Mather KJ; Haupt A; Milicevic Z
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):418-429. PubMed ID: 35468322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a large supper on glucose levels the following morning in patients with type 2 diabetes.
    Arauz-Pacheco C; Clements G; Cercone S; Brinkley L; Raskin P
    J Diabetes Complications; 1998; 12(2):61-4. PubMed ID: 9559482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.
    Basu A; Dalla Man C; Basu R; Toffolo G; Cobelli C; Rizza RA
    Diabetes Care; 2009 May; 32(5):866-72. PubMed ID: 19196896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carbohydrate restriction in the first meal after an overnight fast on glycemic control in people with type 2 diabetes: a randomized trial.
    Pedersen E; Lange K; Clifton P
    Am J Clin Nutr; 2016 Nov; 104(5):1285-1291. PubMed ID: 27733405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
    Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
    Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.